Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Checkpoint Therapeutics, Inc. | Chief Financial Officer | Common Stock | 672K | $1.38M | $2.06 | Jun 26, 2024 | Direct |
Checkpoint Therapeutics, Inc. | Chief Financial Officer | Common Stock (Restricted) | 685K | May 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CKPT | Checkpoint Therapeutics, Inc. | Jun 26, 2024 | 1 | -$26.9K | 4 | Jun 28, 2024 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | May 24, 2024 | 1 | $0 | 4 | May 24, 2024 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | Feb 28, 2024 | 1 | -$4.21K | 4 | Mar 1, 2024 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | Feb 1, 2024 | 1 | -$8.02K | 4 | Feb 2, 2024 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | Feb 27, 2023 | 3 | -$26.9K | 4 | Mar 3, 2023 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | Feb 1, 2023 | 1 | -$15.1K | 4 | Feb 3, 2023 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | Jan 10, 2023 | 1 | -$12.5K | 4 | Jan 12, 2023 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | Mar 10, 2022 | 1 | -$72.3K | 4 | Mar 11, 2022 | Chief Financial Officer |
CKPT | Checkpoint Therapeutics, Inc. | Jan 31, 2022 | 2 | -$93K | 4 | Feb 2, 2022 | Chief Financial Officer |